AU1757092A - Stable growth hormone metal ion formulations - Google Patents

Stable growth hormone metal ion formulations

Info

Publication number
AU1757092A
AU1757092A AU17570/92A AU1757092A AU1757092A AU 1757092 A AU1757092 A AU 1757092A AU 17570/92 A AU17570/92 A AU 17570/92A AU 1757092 A AU1757092 A AU 1757092A AU 1757092 A AU1757092 A AU 1757092A
Authority
AU
Australia
Prior art keywords
metal ion
growth hormone
stable growth
ion formulations
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU17570/92A
Inventor
Brian C. Cunningham
Michael G Mulkerrin
James A Wells
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of AU1757092A publication Critical patent/AU1757092A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/27Growth hormone [GH] (Somatotropin)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormones [GH] (Somatotropin)
AU17570/92A 1991-03-28 1992-03-25 Stable growth hormone metal ion formulations Abandoned AU1757092A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US676645 1984-11-30
US67664591A 1991-03-28 1991-03-28

Publications (1)

Publication Number Publication Date
AU1757092A true AU1757092A (en) 1992-11-02

Family

ID=24715358

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17570/92A Abandoned AU1757092A (en) 1991-03-28 1992-03-25 Stable growth hormone metal ion formulations

Country Status (2)

Country Link
AU (1) AU1757092A (en)
WO (1) WO1992017200A2 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981485A (en) 1997-07-14 1999-11-09 Genentech, Inc. Human growth hormone aqueous formulation
US5763394A (en) * 1988-04-15 1998-06-09 Genentech, Inc. Human growth hormone aqueous formulation
US6022858A (en) * 1991-12-20 2000-02-08 Novo Nordisk A/S Pharmaceutical formulation of human-growth hormone pretreated with zinc salt
SE9201073D0 (en) * 1992-04-03 1992-04-03 Kabi Pharmacia Ab PROTEIN FORMULATION
US6087324A (en) * 1993-06-24 2000-07-11 Takeda Chemical Industries, Ltd. Sustained-release preparation
ZA965368B (en) * 1995-07-14 1997-01-14 Novo Nordisk As A pharmaceutical formulation
DE69719367T2 (en) 1996-12-20 2003-10-16 Takeda Chemical Industries Ltd METHOD FOR PRODUCING A COMPOSITION WITH DELAYED DELIVERY
ZA9711731B (en) * 1996-12-31 1998-07-01 Monsanto Co Aqueous glycerol formulations of somatotropin
US6191107B1 (en) 1997-09-26 2001-02-20 Takeda Chemical Industries, Ltd. Complex of human growth hormone and zinc
CA2308135A1 (en) * 1997-10-31 1999-05-14 John G. Gleason Novel metal complexes
US6280959B1 (en) * 1997-10-31 2001-08-28 Smithkline Beecham Corporation Metal complexes
CA2377585A1 (en) 1999-06-28 2001-01-04 Genentech, Inc. Methods for making apo-2 ligand using divalent metal ions
CA2406790C (en) 2000-04-19 2009-07-07 Genentech, Inc. Sustained release formulations
EP1309312A2 (en) 2000-08-07 2003-05-14 Inhale Therapeutic Systems, Inc. Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
DK1372729T3 (en) 2001-02-23 2009-06-22 Genentech Inc Degradable polymers for injection
AU2002320122B2 (en) * 2001-06-21 2007-07-26 Genentech, Inc. Sustained release formulation
EP1501866A4 (en) 2001-10-02 2006-02-08 Genentech Inc Apo-2 ligand variants and uses thereof
CA2489348A1 (en) 2002-06-24 2003-12-31 Genentech, Inc. Apo-2 ligand/trail variants and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB885798A (en) * 1958-12-06 1961-12-28 Organon Labor Ltd Preparations of the growth hormone
EP0343696B1 (en) * 1984-10-04 1996-01-03 Monsanto Company Zinc-associated somatotropins
IL79681A (en) * 1985-08-12 1991-06-10 Int Minerals & Chem Corp Transition metal complexes of growth hormones and their prolonged release compositions
US5096885A (en) * 1988-04-15 1992-03-17 Genentech, Inc. Human growth hormone formulation

Also Published As

Publication number Publication date
WO1992017200A3 (en) 1992-12-23
WO1992017200A2 (en) 1992-10-15

Similar Documents

Publication Publication Date Title
AU1757092A (en) Stable growth hormone metal ion formulations
AU3095092A (en) Stabilized parathyroid hormone composition
AU1802492A (en) New aqueous formulations
GB2254556B (en) Formulations containing linolenic acid
AU8554691A (en) Improved formulations
AU6254190A (en) Growth hormone-releasing factor analogs
AU2730992A (en) Diabroticine bait
AU2980592A (en) Insecticidal compositions
AU8289891A (en) Improved antiperspirant formulations
AU2419192A (en) Atomic emission spectrometry
AU1904792A (en) Thyroplasty implant
AU2277992A (en) Controllably affecting fertilizer composition
AU1908192A (en) An implant
AU8130391A (en) Solid formulations
AU6111390A (en) Pesticidal formulations
AU1247192A (en) Steroid formulations
AU2395692A (en) Herbicidal composition
AU4979093A (en) Herbicidal composition
AU5870090A (en) Topical formulations
AU4061493A (en) Envelope
AU609660B2 (en) Antiparasitic formulations
AU658500B2 (en) Fungicidal compositions
AU2639192A (en) Herbicidal composition
AU6272490A (en) Biologically active compositions
AU627847B2 (en) Pesticidal formulations